VISICOVER LTD
Company number 07968371 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: VISICOVER LTD
Assessment Date: Based on financial history up to 31 December 2024
1. Financial Health Score: A (Excellent)
The company exhibits the financial equivalent of a clean bill of health. All vital signs are strong, with robust cash reserves, a rapidly strengthening balance sheet, and a complete recovery from earlier years of negative net worth. There are no signs of distress, and the outlook is positive.
2. Key Vital Signs
| Vital Sign | Current Reading (2024) | Trend (5‑Year) | Interpretation |
|---|---|---|---|
| Cash & Cash Equivalents | £729,254 | Up from £233,415 (2020) | Strong pulse – cash has more than tripled in five years, providing a comfortable liquidity buffer. |
| Net Assets (Equity) | £630,444 | Up from £70,695 (2020) | Healthy growth – the company has moved from negative equity in 2016/2017 to a substantial positive position, indicating sustained profitability. |
| Current Ratio (Current Assets ÷ Current Liabilities) | 11.3 : 1 (£814,930 / £72,279) | Consistently >10x over recent years | Excellent short‑term solvency – the company can cover its immediate obligations more than eleven times over. |
| Total Liabilities | £120,000 (long‑term) + £72,279 (short‑term) = £192,279 | Down from £400,000 (2016‑2018) | Debt reduction – total liabilities have been cut by more than half, improving the risk profile. |
| Shareholders’ Funds | £630,444 | Steady upward trend | Resilient capital base – retained earnings have grown every year since 2019, reflecting consistent profit generation. |
Additional Observations: - No overdue filings – accounts and confirmation statement are up to date, indicating good governance. - Low fixed‑asset intensity – the business is asset‑light (tangible fixed assets only £1,767), typical for a service‑based insurance broker. - No director disqualifications – clean conduct records.
3. Diagnosis
Overall Condition: Robust and well‑nourished.
- Heart (Liquidity): Excellent. Cash alone covers all current liabilities nearly ten times over. The company is not reliant on external financing for day‑to‑day operations.
- Lungs (Profitability): Strong. Retained earnings have increased every year since 2019, indicating consistent net profits. The income statement is not filed (small company exemption), but the growth in equity tells the story of a profitable, cash‑generative business.
- Bones (Asset Base): Solid. Total assets have grown from £421k (2020) to £823k (2024), driven almost entirely by cash accumulation. The balance sheet is clean, with no significant intangible or risky assets.
- Blood Pressure (Leverage): Low and falling. Long‑term creditors have been reduced from £180k to £120k in the last year. The company has minimal reliance on debt.
Historical Note: The company began life with negative equity in 2016/2017, a common “start‑up” phase for young brokerages. It has since turned around completely and now enjoys a position of financial strength.
4. Recommendations
Although the company is in excellent health, a few actions can help sustain and optimise its financial wellness:
-
Consider Strategic Deployment of Excess Cash
With over £729k in the bank and negligible short‑term debt, the company could explore: - Modest dividend payments to reward shareholders (subject to retained earnings availability). - Investment in growth – e.g., marketing, technology upgrades, or expanding the product line (aircraft/boat insurance) to capture more market share. - Early repayment of long‑term creditors (£120k) to eliminate all debt and further strengthen the balance sheet. -
Review Long‑Term Liability Structure
The £120k due after more than one year is classified as “other creditors”. Clarify whether this is a director loan or a formal borrowing. If it carries interest, consider refinancing at a lower rate or repaying early. -
Maintain Strong Governance and Filing Discipline
Continue the current practice of timely filings. Consider preparing a voluntary strategic report to give stakeholders more insight into the company’s performance and outlook. -
Monitor Key Ratios Annually
While the current ratio is very high, an excessively large cash pile can be inefficient. Set a target working capital level (e.g., 3–5x current liabilities) and invest surplus cash in low‑risk, income‑generating assets.